drugset / Trial / NCT06329050

The Effects of Losartan on Attention Control: An Eye-tracking Study

NCT06329050

RandomizedParallel-groupDouble-blindBasic science

Summary

The main aim of the present study is to investigate the effects of orally administered Losartan on bottom-up and top-down attentional control to socio-emotional stimuli by combining a validated saccade/antisaccade eye-tracking paradigm with a randomized between-subject placebo-controlled pharmacological trial design.

Timeline

Start
2024-03-05
Primary completion
2025-06-01
Completion
2025-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Losartan Other / unclassified 50 mg Oral

Indications

No indication recorded.